Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05499507 · ClinicalTrials.gov registry record · NA

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

A NA study of Obesity and Hypertension, sponsored by Temple University.

Recruiting
Registry status
NA
Development phase
432
Enrollment target
1
Study location

NCT05499507 is a NA study of Obesity and Hypertension that is actively recruiting participants, run by Temple University. The registered enrollment target is 432 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05499507, a NA study of Obesity and Hypertension, is actively recruiting participants, sponsored by Temple University.

RECRUITING
Registry status
NA
Development phase
432 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.

Interventions

  • BEHAVIORAL COH
  • BEHAVIORAL COH+

Study Locations (1)

Pennsylvania

  • Temple University/Temple Health - Philadelphia

Trial Details

FieldValue
Enrollment Target 432 participants
Start Date 2023-01-24
Est. Completion 2028-12-10
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT05499507

The ClinicalTrials.gov registry entry for NCT05499507 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 432 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (47% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which COH is the first listed.

NCT05499507 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05499507 about?

NCT05499507 is a clinical study titled "The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)". The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.

What is the current status of trial NCT05499507?

This trial is currently recruiting. It is a NA study. The enrollment target is 432 participants. The study started on 2023-01-24. Estimated completion is 2028-12-10.

What conditions does trial NCT05499507 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Pregnancy Related, Racism.

What interventions are being tested in trial NCT05499507?

The interventions under investigation include: COH (BEHAVIORAL), COH+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT05499507?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05499507 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.